Cefuroxime and cefdinir are both oral cephalosporin antibiotics prescribed for many of the same infections, but they differ in generation, dosing convenience, how food affects absorption, and how well they concentrate in urine. Cefuroxime is a second-generation cephalosporin, while cefdinir is third-generation, and though their clinical outcomes in respiratory infections are broadly similar, the practical differences between them matter more than many patients realize.
Where They Overlap in Germ-Killing Power
Both drugs cover the bacteria behind most common community-acquired infections: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus (the methicillin-susceptible kind), and Streptococcus pyogenes. In lab testing, cefdinir and cefuroxime perform similarly against susceptible staphylococci, and both retain some activity against strains of S. pneumoniae with intermediate penicillin resistance.1PubMed. Comparative in vitro activity of cefdinir (CI-983; FK-482) against staphylococci, gram-negative bacilli and respiratory tract pathogens A review of oral cephalosporin potency confirmed that cefdinir and cefuroxime were both highly active against penicillin-susceptible S. pneumoniae, while amoxicillin/clavulanate outperformed both against penicillin-resistant strains.2PubMed. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate
Where the two diverge slightly is H. influenzae. Cefdinir shows the highest susceptibility rates against H. influenzae among orally available cephalosporins, ranging from about 97% to 99%.3PubMed. Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002) Cefuroxime covers H. influenzae too, but its raw potency against that pathogen is a step behind. For most everyday infections, though, the difference is unlikely to change outcomes, because H. influenzae susceptibility rates for cefuroxime are still reasonable in clinical practice.
How They Compare in Head-to-Head Trials
The most direct evidence comes from a multinational randomized trial that pitted cefdinir against cefuroxime axetil in patients with acute flare-ups of chronic bronchitis. Cefdinir given once daily achieved a microbiologic eradication rate of about 90%, compared with 86% for cefuroxime given twice daily. Clinical response rates were also close: 81% for once-daily cefdinir versus 80% for twice-daily cefuroxime.4PubMed Central. International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis In broader reviews of randomized controlled trials across community-acquired pneumonia, sinusitis, otitis media, and pharyngitis, cefdinir at standard doses showed efficacy at least equivalent to other oral agents, cefuroxime included.5PubMed. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections
The bottom line from clinical trials is that, for respiratory and ear-nose-throat infections, picking one over the other rarely changes whether you get better. The decision usually hinges on other practical factors like dosing frequency, cost, and tolerability.
Dosing and Convenience
One of the most noticeable differences between these two antibiotics is how often you take them. Cefdinir can be taken once a day (600 mg for adults) or split into twice-daily doses (300 mg each). Cefuroxime axetil is typically dosed twice daily at 250 mg or 500 mg depending on the infection. For children, cefdinir is available as a suspension dosed at 14 mg/kg/day in one or two divided doses, while cefuroxime suspension is given twice daily.
Once-daily dosing sounds trivial, but adherence research consistently shows that simpler regimens get finished more reliably, especially for children’s courses. If you are a parent trying to wrestle medication into a reluctant four-year-old twice a day for ten days, the appeal of once-daily dosing is hard to overstate. Cefdinir’s suspension also has a reputation for being more palatable, though taste is subjective and varies by brand.
Food, Iron, and Absorption Quirks
This is where the two drugs diverge in ways that genuinely affect how you should take them. Cefuroxime axetil absorbs substantially better when taken with food. A systematic review with meta-analyses found that food increased cefuroxime’s bioavailability by more than 45%, one of the largest positive food effects among oral beta-lactam antibiotics.6Journal of Antimicrobial Chemotherapy. Do dietary interventions exert clinically important effects on the bioavailability of β-lactam antibiotics? A systematic review with meta-analyses If your doctor prescribes cefuroxime, taking it on an empty stomach can cut blood levels meaningfully and may undermine its effectiveness.
Cefdinir, by contrast, is not dramatically affected by food in general, but it has a specific vulnerability: iron. Iron supplements and iron-fortified infant formulas significantly lower cefdinir absorption. The same systematic review found that cefdinir experienced the highest negative impact on bioavailability among beta-lactams when paired with iron salts.7Journal of Antimicrobial Chemotherapy. Do dietary interventions exert clinically important effects on the bioavailability of β-lactam antibiotics? A systematic review with meta-analyses The standard advice is to separate cefdinir doses from iron-containing products by at least two hours. Cefuroxime does not share this interaction, which can make it the simpler choice for patients already on iron supplements or for infants on iron-fortified formula.
The Red Stool Scare
One side effect unique to cefdinir catches parents and emergency physicians off guard: bright red or reddish-brown stools in children who are simultaneously receiving iron. The color comes from a chemical reaction between cefdinir and iron in the gut, forming a reddish complex that looks alarmingly like blood. Case reports describe parents rushing to the emergency department with what appears to be bloody diarrhea, only to find that stool tests for blood come back negative.8PubMed. Emergent “Bloody Diarrhea” Associated with the Use of Oral Cefdinir in Young Children: A Brief Report and Review of Literature The effect is harmless and disappears after cefdinir is stopped or the iron source is removed. But it causes real panic when families aren’t warned in advance, and it generates unnecessary ER visits.
Cefuroxime does not cause red stools. If a child on iron-fortified formula needs an oral cephalosporin, choosing cefuroxime sidesteps this issue entirely. When cefdinir is prescribed anyway, a quick heads-up from the prescriber about possible stool color change can save a lot of worry.
Urinary Tract Infections and Kidney Concentration
This is an area where cefuroxime has a clear pharmacological advantage. After an oral dose, cefuroxime is eliminated largely unchanged through the kidneys, with roughly 42% to 57% of a dose recovered in urine within 24 hours. It achieves high concentrations in both urine and kidney tissue. Cefdinir, by comparison, has much lower urinary recovery, in the range of about 12% to 23% of the dose, and the fraction drops further at higher doses.9Journal of Antimicrobial Chemotherapy. Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections
What this means in practice is that cefuroxime delivers substantially more drug to the actual site of infection in a urinary tract infection. Cefdinir can still work for uncomplicated lower UTIs in susceptible organisms, but the drug concentrations it produces in urine are lower, and some clinicians prefer not to rely on it for this purpose when cefuroxime or other alternatives are available. For upper urinary tract infections like pyelonephritis, the gap in renal tissue penetration matters even more, and cefuroxime is the stronger choice of the two.
Clostridioides difficile Risk
A concern with any antibiotic is the potential to trigger C. difficile infection, the gut pathogen that causes severe diarrhea and colitis. A large case-control study compared the risk associated with different outpatient antibiotics and found that cefdinir, cefuroxime, cefixime, and cefpodoxime all fell in a similar risk range, with odds ratios between roughly 8.5 and 12 compared to people not on antibiotics. Clindamycin carried the highest risk of all, with an odds ratio above 25.10Open Forum Infectious Diseases. Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case–Control Study In other words, neither cefdinir nor cefuroxime is meaningfully safer than the other when it comes to C. difficile. Both carry moderate risk, which is another reason clinicians try to use the narrowest effective antibiotic for the shortest reasonable duration regardless of which one they pick.
How They Handle Resistant Bacteria
Extended-spectrum beta-lactamases are enzymes produced by some gram-negative bacteria that chew up many cephalosporins. Both cefdinir and cefuroxime are affected by these enzymes, and neither should be relied upon against organisms known to produce them.11Antimicrobial Agents and Chemotherapy. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases That said, lab testing of 15 different plasmid-mediated beta-lactamases found cefdinir to be somewhat more stable than cefuroxime against hydrolysis by these enzymes overall, though neither approached the stability of certain later drugs like ceftazidime.12PubMed. Stability of cefdinir (C1-983, FK482) to extended-spectrum plasmid-mediated beta-lactamases
In real-world prescribing, this marginal difference in enzyme stability rarely changes decisions. If you have a documented or suspected ESBL-producing organism, neither oral cephalosporin is appropriate, and the patient usually needs a different class of antibiotic. Where resistance matters day to day is in milder, everyday-pathogen resistance patterns, and local antibiograms (the hospital or region’s resistance data) tend to guide the choice more than any blanket statement about one drug versus the other.
Allergies and Cross-Reactivity
Patients sometimes ask whether they can take one of these drugs if they are allergic to the other. Both are cephalosporins, and the concern about cross-reactivity between cephalosporins and penicillins has been debated for decades. Modern evidence puts the true cross-reaction rate between penicillins and cephalosporins much lower than the older estimates of 10% that still circulate in some textbooks. The risk is highest with first-generation cephalosporins and drops further with second- and third-generation drugs.
Cross-reactivity between two different cephalosporins depends largely on whether they share similar side-chain structures. Cefuroxime and cefdinir have different R1 side chains, so a person who reacts to one does not automatically react to the other. Still, if you have had an anaphylactic reaction to any cephalosporin, most prescribers will want to do a skin test or choose an antibiotic from a completely different class rather than gamble on a different cephalosporin.
When Prescribers Choose One Over the Other
In practice, the choice between cefuroxime and cefdinir often comes down to a handful of patient-specific factors rather than a blanket rule. Here are the situations where one tends to win out:
- UTIs: Cefuroxime is preferred because of its much higher urinary concentration.
- Infants on iron-fortified formula: Cefuroxime avoids both the absorption interaction and the alarming red stools.
- Adherence concerns: Cefdinir’s once-daily option can be a deciding factor, especially in children or adults who struggle with twice-daily schedules.
- Patients who skip meals: Cefdinir is less affected by food timing, whereas cefuroxime needs to be taken with food for adequate absorption.
- Patients on iron supplements: Cefuroxime sidesteps the iron interaction entirely.
For standard respiratory infections, ear infections, sinusitis, and strep throat, either drug works comparably well, and the pick often reflects what the prescriber is accustomed to, what the local resistance data favor, and what the patient’s insurance covers. Cost and formulary status vary by region and insurer, and in some healthcare settings one of the two is simply more available than the other.
Pediatric Prescribing Patterns
Cefdinir became one of the most commonly prescribed oral antibiotics in pediatrics during the 2000s and 2010s, partly because of its once-daily dosing, generally tolerable taste in suspension form, and broad indication list covering otitis media, sinusitis, and pharyngitis. Cefuroxime axetil suspension, on the other hand, has a well-known bitter taste that can make it difficult to administer to young children, even with flavoring. This palatability gap has practical consequences: a ten-day antibiotic course that a child refuses to swallow is worse than useless.
Pediatric guidelines typically list both drugs as second-line options for children with penicillin allergies who need treatment for acute otitis media or bacterial sinusitis, with high-dose amoxicillin remaining the first-line choice in most cases. The American Academy of Pediatrics has long recognized cephalosporins as appropriate alternatives in penicillin-allergic patients, and both cefdinir and cefuroxime appear in those recommendations. When choosing between the two, clinicians weigh the factors above: is the child on iron, does adherence history suggest once-daily is needed, and is the infection in the urinary tract or the respiratory tract?
Shelf Life and Storage
A minor but real practical difference shows up in how the liquid suspensions are stored. Once reconstituted, cefdinir suspension is typically stable for ten days at room temperature, which conveniently matches most prescribed course lengths. Cefuroxime axetil suspension must be refrigerated after reconstitution and also remains stable for about ten days. For families without reliable refrigeration, or for travel situations, cefdinir’s room-temperature storage is a small but tangible advantage. Both suspensions should be shaken well before each dose, and any leftover suspension should be discarded after the treatment course rather than saved for future use.
Pregnancy and Breastfeeding
Both cefuroxime and cefdinir are classified as generally compatible with pregnancy, falling into what the older FDA system labeled Category B, meaning animal studies showed no fetal harm and no adequate controlled studies in pregnant women exist. In practice, cefuroxime has a longer track record of use in pregnancy, particularly for treating urinary tract infections in pregnant patients, and some clinicians feel more comfortable with it on that basis alone. Both drugs pass into breast milk in very small amounts and are considered compatible with breastfeeding by most professional guidelines. Neither requires pumping and dumping during a treatment course.
For pregnant patients with UTIs specifically, cefuroxime’s superior urinary concentration gives it a pharmacological edge on top of its longer safety track record in this population. Cefdinir would be an unusual first choice for a UTI in pregnancy, though it could still be appropriate for respiratory infections when a cephalosporin is needed.